16880785Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJBritish journal of cancerAngiogenesis Inhibitors; Benzenesulfonates; Melanoma; PyridinesAdult; Aged; Aged, 80 and over; DNA Primers; Female; Genes, ras; Humans; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Safety; SorafenibSorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer. 2006 Sep 04; 95(5):581-6.Br J Cancer2006-08-01T00:00:002006Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009367Concepts & IdeasProcedures34719320.6701Neoplasm StagingD012449Phenomena971520.924617SafetyD010671Chemicals & Drugs511130.945905Phenylurea CompoundsD005260Physiology1992444050.191184FemaleAuthorship 3013617D011725Chemicals & Drugs1533090.839063PyridinesD011905Genes & Molecular Sequences50960.959472Genes, rasD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleMedicine-Hematology and Oncology0.294040.294041authors10.2519has subject areaD008545Disorders1634540.720246MelanomaD020533Chemicals & DrugsPhysiology1073090.812525Angiogenesis InhibitorsD048493Chemicals & Drugs701370.902514Proto-Oncogene Proteins B-rafD016133Procedures3549270.826576Polymerase Chain ReactionD001557Chemicals & Drugs29660.952986BenzenesulfonatesD009536Chemicals & Drugs541160.957034NiacinamideD017931Chemicals & Drugs2555420.907646DNA PrimersUniversity of ChicagoMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.Professortrue1ProfessorProfessor